Literature DB >> 3587542

Radiation therapy in the treatment of partially resected meningiomas.

N M Barbaro, P H Gutin, C B Wilson, G E Sheline, E B Boldrey, W M Wara.   

Abstract

To address the question of whether radiation therapy is beneficial in the management of partially resected meningiomas, we reviewed the records of all patients admitted to the University of California, San Francisco, between 1968 and 1978 who had a diagnosis of intracranial meningioma. The patients were divided into three groups: 51 patients had gross total resection and did not receive radiation therapy, 30 patients had subtotal resection and no radiation therapy, and 54 patients had subtotal resection followed by radiation therapy. The subtotal resection groups were similar in average age, male:female ratio, and tumor location, which allowed a valid comparison of the effects of irradiation. The recurrence rate in the total resection group was 4% (2 of 51 patients). Among patients in the subtotal resection groups, 60% of nonirradiated patients had a recurrence, compared with only 32% of the irradiated patients. The median time to recurrence was significantly longer in the irradiated group than in the nonirradiated group (125 vs. 66 months, P less than 0.05). There was no complication related to irradiation. These results provide convincing evidence that radiation therapy is beneficial in the treatment of partially resected meningiomas.

Entities:  

Mesh:

Year:  1987        PMID: 3587542     DOI: 10.1227/00006123-198704000-00003

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  50 in total

1.  Impaired survival and long-term neurological problems in benign meningioma.

Authors:  Hanna van Alkemade; Michelle de Leau; Edith M T Dieleman; Jan W P F Kardaun; Rob van Os; W Peter Vandertop; Wouter R van Furth; Lukas J A Stalpers
Journal:  Neuro Oncol       Date:  2012-03-09       Impact factor: 12.300

2.  Non-resectable slow-growing meningiomas treated by hydroxyurea.

Authors:  David Loven; Ruth Hardoff; Zvi Bar Sever; Adam P Steinmetz; Michael Gornish; Zvi H Rappaport; Eyal Fenig; Zvi Ram; Aaron Sulkes
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 3.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

Review 4.  Fractionated radiotherapy for intracranial meningiomas.

Authors:  Vinai Gondi; Wolfgang A Tome; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

5.  Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma.

Authors:  A Gabriella Wernicke; Adam P Dicker; Michal Whiton; Jana Ivanidze; Terry Hyslop; Elizabeth H Hammond; Arie Perry; David W Andrews; Lawrence Kenyon
Journal:  Radiat Oncol       Date:  2010-05-30       Impact factor: 3.481

6.  Sellar meningiomas: an endocrinologic perspective.

Authors:  Matheni Sathananthan; Airani Sathananthan; Bernd W Scheithauer; Caterina Giannini; Fredric B Meyer; John L D Atkinson; Dana Erickson
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

Review 7.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

8.  Temporal bone meningiomas.

Authors:  F D Vrionis; J H Robertson; G Gardner; C B Heilman
Journal:  Skull Base Surg       Date:  1999

9.  Rate of progression and severity of neuro-ophthalmologic manifestations of cavernous sinus meningiomas.

Authors:  K C Golnik; N R Miller; D M Long
Journal:  Skull Base Surg       Date:  1992

10.  Intracranial meningiomas. Analysis of 344 surgically treated cases.

Authors:  N Altinörs; L Gürses; N Arda; A Türker; E Senveli; T Dönmez; M Sanli; M Bavbek; H Caner
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.